The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Benefit-risk preferences for treatments for newly-diagnosed multiple myeloma.
 
Shelby D Reed
Stock and Other Ownership Interests - ABBVIE/ABBOTT (I); GE Healthcare Technologies (I); Gilead Sciences (I); LabCorp (I); Merck (I); MiMedx (I); Sage Therapeutics (I); United Health Group (I); Vertex (I)
Honoraria - LabCorp
Consulting or Advisory Role - COVIA Health Solutions; Sage Therapeutics; Sarepta Therapeutics
Research Funding - Abbott Vascular (Inst); AstraZeneca (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Janssen Research & Development (Inst); Novartis (Inst)
 
Jessie Sutphin
No Relationships to Disclose
 
Matthew J Wallace
Research Funding - Janssen Research & Development (Inst)
 
Laura Hester
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Janssen; Oracle Health Sciences (I)
 
Tito Roccia
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Ellen Janssen
Employment - Johnson & Johnson/Janssen
Stock and Other Ownership Interests - Johnson & Johnson/Janssen
Travel, Accommodations, Expenses - Johnson & Johnson/Janssen
 
Thomas William LeBlanc
Honoraria - Agilix Health; Lilly
Consulting or Advisory Role - Abbvie/Genentech; Agios/Servier; Astellas Pharma; BeiGene; Blue Note Therapeutics; Bristol-Myers Squibb/Celgene; Flatiron Health; GlaxoSmithKline; Novartis; Pfizer
Speakers' Bureau - Abbvie; Agios; Bristol-Myers Squibb/Celgene; Incyte; SERVIER
Research Funding - Bristol Myers Squibb (Inst); Jazz Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - UpToDate Inc., royalty
Travel, Accommodations, Expenses - Abbvie/Genentech; Agios; Bristol-Myers Squibb/Celgene; Incyte